United States securities and exchange commission logo November 23, 2020 Gilad Glick Chief Executive Officer Itamar Medical Ltd. 9 Halamish Street Caesarea 3088900, Israel Re: Itamar Medical Ltd. Registration Statement on Form F-3 Filed November 18, 2020 File No. 333-250155 Dear Mr. Glick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nathan Ajiashvili, Esq.